Lipidomics Gateway - Update - nature.com science feeds http://www.lipidmaps.org Nature Publishing Group en © 2012 Nature Publishing Group Lipidomics Gateway 2040-3453 © 2012 Nature Publishing Group permissions@nature.com Lipidomics Gateway http://www.nature.com/includes/rj_globnavimages/lipidmaps_logo.gif http://www.lipidmaps.org Vitamin K http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/lnjQDr5eWi4/lipidmaps.2012.10.html An essential cofactor for the carboxylation of glutamic acid residues in several proteins, vitamin K is most renowned for its role in blood clotting but is gaining recognition for its involvement in other cellular processes such as apoptosis and signal transduction. Vitamin K

Lipidomics Gateway (2012). doi:10.1038/lipidmaps.2012.10

Author: Katrin Legg

An essential cofactor for the carboxylation of glutamic acid residues in several proteins, vitamin K is most renowned for its role in blood clotting but is gaining recognition for its involvement in other cellular processes such as apoptosis and signal transduction.

]]> Vitamin K Katrin Legg doi:10.1038/lipidmaps.2012.10 Lipidomics Gateway (2012) 2012-04-25 Lipidomics Gateway 2012-04-25 10.1038/lipidmaps.2012.10 http://dx.doi.org/10.1038/lipidmaps.2012.10 Research Highlight http://www.lipidmaps.org/update/2012/120501/full/lipidmaps.2012.10.html Diabetes-accelerated atherosclerosis: Myeloid ACSL1 is a key perpetrator http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/_geTHhnYxs4/lipidmaps.2012.11.html Myeloid-specific deficiency of ACSL1, which promotes the production of the lipid-derived inflammatory mediator PGE2 and inflammatory cytokines, prevents diabetes-accelerated atherosclerosis. Diabetes-accelerated atherosclerosis: Myeloid ACSL1 is a key perpetrator

Lipidomics Gateway (2012). doi:10.1038/lipidmaps.2012.11

Author: Katrin Legg

Myeloid-specific deficiency of ACSL1, which promotes the production of the lipid-derived inflammatory mediator PGE2 and inflammatory cytokines, prevents diabetes-accelerated atherosclerosis.

]]> Diabetes-accelerated atherosclerosis: Myeloid ACSL1 is a key perpetrator Katrin Legg doi:10.1038/lipidmaps.2012.11 Lipidomics Gateway (2012) 2012-04-25 Lipidomics Gateway 2012-04-25 10.1038/lipidmaps.2012.11 http://dx.doi.org/10.1038/lipidmaps.2012.11 Research Highlight http://www.lipidmaps.org/update/2012/120501/full/lipidmaps.2012.11.html Type 2 diabetes: Fatty acids deliver double whammy http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/AWR7GxRfH2c/lipidmaps.2012.12.html In response to increased palmitate levels, β cells secrete chemokines, thereby promoting macrophage recruitment, inflammation and subsequent dysfunction. Type 2 diabetes: Fatty acids deliver double whammy

Lipidomics Gateway (2012). doi:10.1038/lipidmaps.2012.12

Author: Katrin Legg

In response to increased palmitate levels, β cells secrete chemokines, thereby promoting macrophage recruitment, inflammation and subsequent dysfunction.

]]> Type 2 diabetes: Fatty acids deliver double whammy Katrin Legg doi:10.1038/lipidmaps.2012.12 Lipidomics Gateway (2012) 2012-04-25 Lipidomics Gateway 2012-04-25 10.1038/lipidmaps.2012.12 http://dx.doi.org/10.1038/lipidmaps.2012.12 Research Highlight http://www.lipidmaps.org/update/2012/120501/full/lipidmaps.2012.12.html Lipids: Monoclonal antibody therapy lowers LDL-cholesterol levels http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/8QrYQXioOKM/nrcardio.2012.55.html Lipids: Monoclonal antibody therapy lowers LDL-cholesterol levels

Nature Reviews Cardiology , (2012). doi:10.1038/nrcardio.2012.55

Author: Ellen F. Carney

]]> Lipids: Monoclonal antibody therapy lowers LDL-cholesterol levels Ellen F. Carney doi:10.1038/nrcardio.2012.55 Nature Reviews Cardiology , (2012) 2012-04-10 Lipidomics Gateway 2012-04-10 10.1038/nrcardio.2012.55 http://dx.doi.org/10.1038/nrcardio.2012.55 Research Highlight http://www.lipidmaps.org/update/2012/120501/full/nrcardio.2012.55.html Apoptosis: Sphingolipid cofactors http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/3mEyJoPWbzM/nchembio.945.html Apoptosis: Sphingolipid cofactors

Nature Chemical Biology 8, 410 (2012). doi:10.1038/nchembio.945

Author: Amy Donner

]]> Apoptosis: Sphingolipid cofactors Amy Donner doi:10.1038/nchembio.945 Nature Chemical Biology 8, 410 (2012) 2012-04-17 Lipidomics Gateway 2012-04-17 10.1038/nchembio.945 http://dx.doi.org/10.1038/nchembio.945 8 5 Research Highlight 410 410 http://www.lipidmaps.org/update/2012/120501/full/nchembio.945.html Complex traits: Old meets new in obesity genetics http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/cYT22X6Gfyo/nrg3223.html Complex traits: Old meets new in obesity genetics

Nature Reviews Genetics 13, 301 (2012). doi:10.1038/nrg3223

Author: Darren J. Burgess

]]> Complex traits: Old meets new in obesity genetics Darren J. Burgess doi:10.1038/nrg3223 Nature Reviews Genetics 13, 301 (2012) 2012-04-03 Lipidomics Gateway 2012-04-03 10.1038/nrg3223 http://dx.doi.org/10.1038/nrg3223 13 5 Research Highlight 301 301 http://www.lipidmaps.org/update/2012/120501/full/nrg3223.html Neurodegenerative disease: RXR agonist reverses Alzheimer's disease http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/BpvrBKuQ8dI/nrd3706.html Neurodegenerative disease: RXR agonist reverses Alzheimer's disease

Nature Reviews Drug Discovery 11, 271 (2012). doi:10.1038/nrd3706

Author: Sarah Crunkhorn

]]> Neurodegenerative disease: RXR agonist reverses Alzheimer's disease Sarah Crunkhorn doi:10.1038/nrd3706 Nature Reviews Drug Discovery 11, 271 (2012) 2012-03-30 Lipidomics Gateway 2012-03-30 10.1038/nrd3706 http://dx.doi.org/10.1038/nrd3706 11 4 Research Highlight 271 271 http://www.lipidmaps.org/update/2012/120501/full/nrd3706.html Biologics inch toward cholesterol-lowering market http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/ek_zQANuhS0/nbt0412-302 Biologics inch toward cholesterol-lowering market

Lipidomics Gateway 302 (2012). doi:10.1038/nbt0412-302

Author: Ken Garber

]]> Biologics inch toward cholesterol-lowering market Ken Garber doi:10.1038/nbt0412-302 Lipidomics Gateway 302 (2012) 2012-04-10 Lipidomics Gateway 2012-04-10 10.1038/nbt0412-302 http://dx.doi.org/10.1038/nbt0412-302 302 304 http://dx.doi.org/10.1038/nbt0412-302 Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/1dbnv_Zn3oc/pnas.1110460109 Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors

Lipidomics Gateway (May 2012). http://dx.doi.org/10.1073/pnas.1110460109

Gregus A., Doolen S., Dumlao D., Buczynski M., Takasusuki T. et al.

]]> Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors 10.1073/pnas.1110460109 Lipidomics Gateway (May 2012) Lipidomics Gateway Research Library 10.1073/pnas.1110460109 http://dx.doi.org/10.1073/pnas.1110460109 http://dx.doi.org/10.1073/pnas.1110460109 Gene-expression measurement: variance-modeling considerations for robust data analysis http://feeds.nature.com/~r/lipidomicsgateway/rss/update/~3/AxPJjBvvAhw/ni.2244 Gene-expression measurement: variance-modeling considerations for robust data analysis

Lipidomics Gateway (May 2012). http://dx.doi.org/10.1038/ni.2244

Subramaniam S. and Hsiao G.

]]> Gene-expression measurement: variance-modeling considerations for robust data analysis 10.1038/ni.2244 Lipidomics Gateway (May 2012) Lipidomics Gateway Research Library 10.1038/ni.2244 http://dx.doi.org/10.1038/ni.2244 http://dx.doi.org/10.1038/ni.2244